Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2011-04-08

FDA Approved: CYANOKIT — Supplemental Application (BTG INTERNATIONAL INC.)

View source ↗

Summary

FDA approved a supplemental application for Cyanokit (hydroxocobalamin) filed by BTG International Inc., expanding its regulatory approval.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cyanokit (hydroxocobalamin)

Snippet

SUPPL AP for CYANOKIT (HYDROXOCOBALAMIN)